141 related articles for article (PubMed ID: 37898264)
1. Extent of Surgical Resection as a Predictor of Tumor Progression in Skull Base Chordomas: A Multicenter Volumetric Analysis.
Perez-Vega C; Akinduro OO; Ruiz-Garcia HJ; Ghaith AKA; Almeida JP; Jentoft ME; Mahajan A; Janus JR; Bendok BR; Choby GW; Middlebrooks EH; Trifiletti DM; Chaichana KL; Laack NN; Quinones-Hinojosa A; Van Gompel JJ
World Neurosurg; 2024 Jan; 181():e620-e627. PubMed ID: 37898264
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients.
Wang L; Wu Z; Tian K; Wang K; Li D; Ma J; Jia G; Zhang L; Zhang J
J Neurosurg; 2017 Dec; 127(6):1257-1267. PubMed ID: 28059654
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas.
Lin E; Scognamiglio T; Zhao Y; Schwartz TH; Phillips CD
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1509-1514. PubMed ID: 29903925
[TBL] [Abstract][Full Text] [Related]
4. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
5. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
Freeman JL; Kaufmann AB; Everson RG; DeMonte F; Raza SM
Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):27-36. PubMed ID: 29912434
[TBL] [Abstract][Full Text] [Related]
6. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas.
Ouyang T; Zhang N; Zhang Y; Jiao J; Ren J; Huang T; Chen J
World Neurosurg; 2014; 81(5-6):790-7. PubMed ID: 23298670
[TBL] [Abstract][Full Text] [Related]
8. Clival chordomas: considerations after 16 years of endoscopic endonasal surgery.
Zoli M; Milanese L; Bonfatti R; Faustini-Fustini M; Marucci G; Tallini G; Zenesini C; Sturiale C; Frank G; Pasquini E; Mazzatenta D
J Neurosurg; 2018 Feb; 128(2):329-338. PubMed ID: 28409727
[TBL] [Abstract][Full Text] [Related]
9. The Significance of Intraoperative Magnetic Resonance Imaging in Resection of Skull Base Chordomas.
Metwali H; Samii A; Gerganov V; Giordano M; Fahlbusch R; Samii M
World Neurosurg; 2019 Aug; 128():e185-e194. PubMed ID: 31003024
[TBL] [Abstract][Full Text] [Related]
10. Surgical Resection and Adjuvant Radiation Therapy in the Treatment of Skull Base Chordomas.
Sanusi O; Arnaout O; Rahme RJ; Horbinski C; Chandler JP
World Neurosurg; 2018 Jul; 115():e13-e21. PubMed ID: 29545225
[TBL] [Abstract][Full Text] [Related]
11. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
Zuckerman SL; Bilsky MH; Laufer I
World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
[TBL] [Abstract][Full Text] [Related]
12. Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients.
Ioakeim-Ioannidou M; Niemierko A; Kim DW; Tejada A; Urell T; Leahy S; Adams J; Fullerton B; Nielsen GP; Hung YP; Shih AR; Patino M; Buch K; Rincon S; Kelly H; Cunnane MB; Tolia M; Widemann BC; Wedekind MF; John L; Ebb D; Shin JH; Cote G; Curry W; MacDonald SM
Neuro Oncol; 2023 Sep; 25(9):1686-1697. PubMed ID: 37029730
[TBL] [Abstract][Full Text] [Related]
13. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas.
Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J
Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic Approach to Clival Chordomas: The Northwestern Experience.
Rahme RJ; Arnaout OM; Sanusi OR; Kesavabhotla K; Chandler JP
World Neurosurg; 2018 Feb; 110():e231-e238. PubMed ID: 29104156
[TBL] [Abstract][Full Text] [Related]
15. Male sex as a risk factor for the clinical course of skull base chordomas.
Rachinger W; Eigenbrod S; Dützmann S; Simon M; Feigl GC; Kremenevskaja N; Kretzschmar H; Zausinger S; Kreth FW; Thon N; Tonn JC
J Neurosurg; 2014 Jun; 120(6):1313-20. PubMed ID: 24405075
[TBL] [Abstract][Full Text] [Related]
16. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
Pamir MN; Ozduman K
Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of different degrees of resection of skull base chordoma.
Wang Y; Peng Z; Wang Y; Fan R; Zhang H; Jiang W
Clin Transl Oncol; 2022 Dec; 24(12):2441-2452. PubMed ID: 35953670
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and patterns of care in adult skull base chordomas from the Surveillance, Epidemiology, and End Results (SEER) database.
Jones PS; Aghi MK; Muzikansky A; Shih HA; Barker FG; Curry WT
J Clin Neurosci; 2014 Sep; 21(9):1490-6. PubMed ID: 24852903
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery.
Hu YS; Lee CC; Wu CA; Lin CJ; Yang HC; Guo WY; Liu KD; Chung WY; Shiau CY; Wu HM
J Neurooncol; 2023 Jan; 161(1):45-56. PubMed ID: 36565364
[TBL] [Abstract][Full Text] [Related]
20. Multimodality management of 26 skull-base chordomas with 4-year mean follow-up: experience at a single institution.
Pamir MN; Kiliç T; Türe U; Ozek MM
Acta Neurochir (Wien); 2004 Apr; 146(4):343-54; discusion 354. PubMed ID: 15057528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]